Fidelity Investments
ARTL icon

Fidelity Investments’s Artelo Biosciences ARTL Stock Holding History

Fidelity Investments’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$138 – 5429
2025
Q3 		$138 Buy
+10
New +$306 ﹤0.01% 5178
2025
Q2 		– Hold
0
– – – 5281
2023
Q4 		– Sell
-1
Closed -$29 – 5427
2023
Q3 		$29 Buy
+1
New +$33 ﹤0.01% 5020
2022
Q1 		– Hold
0
– – – 4931
2021
Q4 		– Hold
0
– – – 4301
2021
Q3 		– Hold
0
– – – 4308
2021
Q2 		– Hold
0
– – – 4210

Other funds holding ARTL

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fidelity Investments's ARTL Position: Q4 2025 in Review

Fidelity Investments sold out of Artelo Biosciences (ARTL) in Q4 2025, closing a stake of 10 shares — an estimated $138 sold.

Fidelity Investments first reported a position in ARTL in Q3 2023 and held it in 2 quarters. The position peaked at $138 in Q3 2025. 8 funds tracked by Wall St. Rank hold ARTL as of Q4 2025.

  • Fidelity Investments reported no remaining Artelo Biosciences position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 10 Artelo Biosciences shares in Q4 2025, an estimated $138.
  • Fidelity Investments first reported a position in Artelo Biosciences in Q3 2023 and held it in 2 quarters.
  • Fidelity Investments's Artelo Biosciences position peaked at $138 in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Artelo Biosciences as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.